Status:
TERMINATED
Atrial Fibrillation Trial to Evade Recurrence: effectS of Hiit Before electrO-Cardioversion for 3-weeKs
Lead Sponsor:
Ottawa Heart Institute Research Corporation
Collaborating Sponsors:
Cardiac Arrhythmia Network of Canada
Conditions:
Persistent Atrial Fibrillation
Eligibility:
All Genders
18-85 years
Phase:
NA
Brief Summary
This is a study looking at the feasibility of conducting a larger definitive research trial looking at the effectiveness of high intensity interval training in individuals who are scheduled for electr...
Detailed Description
This is a study looking at the feasibility of conducting a larger definitive research trial looking at the effectiveness of high intensity interval training on lengthening time to recurrence of persis...
Eligibility Criteria
Inclusion
- Persistent atrial fibrillation
- Eligible and scheduled for electro-cardioversion at UOHI
- Rate controlled with a resting ventricular rate of equal to or less than 100bpm
- Between 18-85 years of age
- Owns a Smartphone
- Physically able to participate in exercise
- Willing and able to provide written, informed consent
- Willing and able to return for follow-up visits
- Willing and able to provide daily ECG recordings using the AliveCor system for the duration of the study.
Exclusion
- Participating in routine exercise training (more than two times per week) in the past 3 months
- Atrial Flutter secondary to ablation
- Unstable angina
- Diagnosed with severe mitral or aortic stenosis, hypertrophic obstructive cardiomyopathy
- Pregnant, lactating or planning to become pregnant during the study period
- Diagnosed with rheumatic heart disease
Key Trial Info
Start Date :
April 25 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 8 2020
Estimated Enrollment :
12 Patients enrolled
Trial Details
Trial ID
NCT03467633
Start Date
April 25 2018
End Date
October 8 2020
Last Update
November 2 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Ottawa Heart Institute
Ottawa, Ontario, Canada, K1Z5P7